Interestingly, mutations in the N-terminal basic domain of SEPT9 are even more prevalent (~45% of total) in intestinal cancers and mutations in the acidic proline-rich domain of SEPT9 are notably elevated (>20% of total) in stomach cancers (Figures 8B,C). Here, SEPTIN9 is linked to gastric neoplasm.